Delivery Order SPE2DR25D3010-SPE2DR26F88DG
- Not listed
- The Defense Logistics Agency awarded a $17,260.58 delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. The contract was competitively awarded without set-aside provisions on September 24, 2025, with an ultimate completion date of October 16, 2025. This delivery order operates under a firm fixed-price arrangement and is performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $9,053.16 delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Ofev 150 mg capsules, a pulmonary fibrosis treatment medication. This non-set-aside, firm fixed-price contract was awarded on December 4, 2025, with an ultimate completion date of December 26, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical products will be delivered to the Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for 60 capsules of Ofev 150 mg, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. The order carries a ceiling value of $17,181.16 under a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. This award represents a non-set-aside, competitively awarded contract issued to the Conshohocken, Pennsylvania-based pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 150 mg, a pulmonary fibrosis treatment medication, with a ceiling value of $18,106.32. The award, issued on November 24, 2025, is scheduled for completion by December 16, 2025, and utilizes firm fixed-price pricing with no set-aside designation. Performance of this delivery order will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 units of Ofev 100 mg capsules, a medication used to treat idiopathic pulmonary fibrosis. This competitively awarded, non-set-aside contract was issued on October 30, 2025, with a ceiling value of $8,630.29 and an ultimate completion date of November 21, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a ceiling value of $9,053.16 and a firm fixed price structure. This non-set-aside competitive award is set to conclude on December 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $9,053.16 delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 150 mg on November 26, 2025, with an ultimate completion date of December 18, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a $18.1K firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 150 mg, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of January 5, 2026. This delivery order leverages AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Ofev 100 mg capsules (60-count units) valued at $8,355.26 under a firm fixed-price contract. This award represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle that runs through December 2026. The delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,094.99 on December 1, 2025, for the supply of Ofev (nintedanib) 100 mg capsules in quantities of 60 units. This firm fixed-price delivery order, with an ultimate completion date of December 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and...
- SPE2DR25D3010Indefinite Delivery Contract
- SPE2DR25D3010-SPE2DR26F88DGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,094.99 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg, a pharmaceutical product used in the treatment of pulmonary fibrosis. The contract is classified as a firm fixed price delivery order with an ultimate completion date of December 24, 2025, and was competitively awarded without any set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to military healthcare systems and other federal customers worldwide. AmerisourceBergen's established role as a major pharmaceutical distributor and federal medical procurement vendor positions it as a critical supplier within the Defense Health Agency's supply chain, supporting military personnel, veterans, and other government healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 12/2/25 |